
Congress is advancing legislation that commits at least $19.4 billion over the next five years—while establishing a permanent, multi-billion-dollar annual funding stream with no defined end date—to build a standing, nationwide influenza response system spanning vaccine development, stockpiling, testing, and public behavior campaigns















